5386662026-04-012026-06-305386662026-04-012026-06-30in-capmkt:OtherExpenses1Member5386662026-04-012026-06-30in-capmkt:OtherExpenses2Member5386662026-04-012026-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15386662026-04-012026-06-30AuditorDomain1iso4217:INRiso4217:INRxbrli:shares538666SHARDACROPNOTLISTEDINE221J01015SHARDA CROPCHEM LIMITEDMain BoardEquity2026-04-012027-03-312026-07-292026-07-21INRLakhsQuarterlyFirst quarterSingle segmentThe consolidated financial statements of the Company contains segment information as per IND AS 108 - Operating Segments accordingly separate information is not included in the Standalone financial results.2026-07-2912:30:002026-07-2914:00:00Declaration of unmodified opinionfalsefalseNot Applicable2026-04-012026-06-30UnauditedStandalone968886000010697190001075857900037351510003180400000-71912600013902700013243000100229500016378160008988806000176977300001769773000306314000575700003638840000140588900000001405889000-9200014057970009022050001015.5815.580015.5815.58Quarterly earnings per share is not annualised <br /> Notes <br /> <br /> 1. The aforesaid financial results have been reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on July 29 2026. The statutory auditors have expressed an unmodified conclusion on these results. <br /> <br /> 2. The financial results for all the periods presented have been prepared in accordance with the recognition and measurement principles of Ind AS notified under the Companies Indian Accounting Standards Rules 2015 as amended from time to time. <br /> <br /> 3. The figures for the quarter ended March 31 2026 are the balancing figures between the audited figures in respect of the full financial year ended on that date and the published unaudited year to date figures upto December 31 2025. <br /> <br /> 4.Other expenses or income includes loss or gain on fair valuation of investments as under <br /> <br /> Particulars Three months ended Year ended <br /> June 30 March 31 June 30 March 31 <br /> 2026 2026 2025 2026 <br /> <br /> Loss or gain on fair valuation of <br /> investments -367.48 1450.25 -273 1115.92 <br /> <br /> 5.Other income includes <br /> <br /> Particulars Three months ended Year ended <br /> June 30 March 31 June 30 March 31 <br /> 2026 2026 2025 2026 <br /> <br /> Dividend received from subsidiary 7542.24 6889.00 - 13608.80 <br /> <br /> 6. One of the major segments of the Company viz. Agrochemicals is seasonal in nature and its performance can be impacted by cropping pattern and weather conditions across the globe. Therefore quarterly figures are not representative of the other quarters and full year's performance. <br /> <br /> 7. The consolidated financial statements of the Company contains segment information as per IND AS 108 - Operating Segments accordingly separate information is not included in the Standalone financial results. <br /> Foreign Exchange Gain Loss-61110000Other Expenses1698926000Gratuity Paid-123000-123000-31000-92000UnauditedtrueBSR & Co. LLPtrue2028-07-31